Cue Biopharma, Inc. (CUE)

27.88 -0.28 (-0.99%) USD  |  NASDAQ  |  Aug 28, 16:00
28.18 +0.30 (+1.08%) After-Hours: 20:00
More

Cue Biopharma Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for CUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 28, 2026 --
August 25, 2026 --
August 17, 2026 --
May 15, 2026 --
November 28, 2025 --
November 18, 2025 --
November 17, 2025 --
August 25, 2025 --
August 22, 2025 --
August 13, 2025 --
May 23, 2025 --
May 19, 2025 --
April 21, 2025 --
April 15, 2025 --
April 02, 2025 --
Date Value
April 01, 2025 --
November 18, 2024 --
November 15, 2024 --
November 11, 2024 --
September 27, 2024 --
August 20, 2024 --
July 29, 2024 --
July 26, 2024 --
July 25, 2024 --
June 06, 2024 --
May 16, 2024 --
May 10, 2024 --
April 09, 2024 --
April 03, 2024 --
March 13, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Equillium, Inc. Upgrade
Legend Biotech Corp. Upgrade
Nurix Therapeutics, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade